Tablet
Latest Warner-Lambert Company Patents:
- Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Description
FIG. 1 is a top side perspective view of a tablet showing my new design, on an enlarged scale;
FIG. 2 is an end elevational view thereof, the other end being identical;
FIG. 3 is a top plan view thereof, the bottom view being identical;
FIG. 4 is a side elevational view thereof, the other side being identical.
Referenced Cited
Patent History
Patent number: D315223
Type: Grant
Filed: May 3, 1989
Date of Patent: Mar 5, 1991
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: Joseph P. Estwin (Succasunna, NJ)
Primary Examiner: Susan J. Lucas
Assistant Examiner: M. H. Tung
Attorney: Elizabeth M. Anderson
Application Number: 7/346,841
Type: Grant
Filed: May 3, 1989
Date of Patent: Mar 5, 1991
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventor: Joseph P. Estwin (Succasunna, NJ)
Primary Examiner: Susan J. Lucas
Assistant Examiner: M. H. Tung
Attorney: Elizabeth M. Anderson
Application Number: 7/346,841
Classifications
Current U.S. Class:
D28/2
